ONCOLOGY INSTITUTE INC/THE (TOI) Stock Price, Quote, News and Overview
NASDAQ:TOI - Nasdaq - US68236X1000 - Common Stock - Currency: USD
TOI Quote, Performance and Key Statistics
3.31
+0.08 (+2.48%)
The current stock price of TOI is 3.31 USD. In the past month the price increased by 198.2%. In the past year, price increased by 187.83%.
TOI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 14.48 | 80.73B | ||
| THC | TENET HEALTHCARE CORP | 10.26 | 11.52B | ||
| EHC | ENCOMPASS HEALTH CORP | 24.22 | 11.42B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.32 | 11.19B | ||
| ENSG | ENSIGN GROUP INC/THE | 22.92 | 7.26B | ||
| SGRY | SURGERY PARTNERS INC | 22.85 | 2.74B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 9.36 | 2.72B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 10.52 | 2.24B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 6.71 | 2.04B | ||
| ARDT | ARDENT HEALTH PARTNERS INC | 8.35 | 1.79B | ||
| PACS | PACS GROUP INC | 12.63 | 1.49B | ||
| NHC | NATIONAL HEALTHCARE CORP | 14.46 | 1.46B |
Related stock screener links
About TOI
Company Profile
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Company Info
ONCOLOGY INSTITUTE INC/THE
18000 Studebaker Rd, Suite 800
Cerritos CALIFORNIA US
CEO: Steven Hochberg
Employees: 800
Company Website: https://theoncologyinstitute.com/
Investor Relations: https://investors.theoncologyinstitute.com/
Phone: 15627353226
ONCOLOGY INSTITUTE INC/THE / TOI FAQ
What is the stock price of ONCOLOGY INSTITUTE INC/THE today?
The current stock price of TOI is 3.31 USD. The price increased by 2.48% in the last trading session.
What is the ticker symbol for ONCOLOGY INSTITUTE INC/THE stock?
The exchange symbol of ONCOLOGY INSTITUTE INC/THE is TOI and it is listed on the Nasdaq exchange.
On which exchange is TOI stock listed?
TOI stock is listed on the Nasdaq exchange.
What is ONCOLOGY INSTITUTE INC/THE worth?
ONCOLOGY INSTITUTE INC/THE (TOI) has a market capitalization of 290.49M USD. This makes TOI a Micro Cap stock.
How many employees does ONCOLOGY INSTITUTE INC/THE have?
ONCOLOGY INSTITUTE INC/THE (TOI) currently has 800 employees.
Is ONCOLOGY INSTITUTE INC/THE (TOI) expected to grow?
The Revenue of ONCOLOGY INSTITUTE INC/THE (TOI) is expected to grow by 16.43% in the next year. Check the estimates tab for more information on the TOI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ONCOLOGY INSTITUTE INC/THE (TOI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TOI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TOI, evaluating the profitability, health, valuation and growth aspects
- ONCOLOGY INSTITUTE INC/THE (TOI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ONCOLOGY INSTITUTE INC/THE (TOI) Sales and EPS estimates to see what analysts future expectations are.
- ONCOLOGY INSTITUTE INC/THE (TOI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ONCOLOGY INSTITUTE INC/THE (TOI) Insider and Institutional Ownership to learn about the owners and their transactions.
- ONCOLOGY INSTITUTE INC/THE (TOI) Stock Chart to make your own analysis
- ONCOLOGY INSTITUTE INC/THE (TOI) Latest news and press-releases to stay up to date.
Does ONCOLOGY INSTITUTE INC/THE (TOI) stock pay dividends?
TOI does not pay a dividend.
When does ONCOLOGY INSTITUTE INC/THE (TOI) report earnings?
ONCOLOGY INSTITUTE INC/THE (TOI) will report earnings on 2025-05-14.
What is the Price/Earnings (PE) ratio of ONCOLOGY INSTITUTE INC/THE (TOI)?
ONCOLOGY INSTITUTE INC/THE (TOI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.71).
What is the Short Interest ratio of ONCOLOGY INSTITUTE INC/THE (TOI) stock?
The outstanding short interest for ONCOLOGY INSTITUTE INC/THE (TOI) is 1.73% of its float. Check the ownership tab for more information on the TOI short interest.
TOI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to TOI. When comparing the yearly performance of all stocks, TOI is one of the better performing stocks in the market, outperforming 99.63% of all stocks.
TOI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TOI. Both the profitability and financial health of TOI have multiple concerns.
TOI Financial Highlights
Over the last trailing twelve months TOI reported a non-GAAP Earnings per Share(EPS) of -0.71. The EPS increased by 22.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.69% | ||
| ROE | -1476.73% | ||
| Debt/Equity | 25.95 |
TOI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to TOI. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 61.9% and a revenue growth 16.43% for TOI